<!doctype html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Ischemic Heart Disease - Clinical Study Note</title>
    <style>
      :root {
        --bg: #f8fbff;
        --surface: #ffffff;
        --ink: #12243d;
        --muted: #54677d;
        --line: #d7e3f0;
        --brand: #7a1f1f;
        --brand-soft: #fff0ef;
        --teal-soft: #eefbf8;
        --warn-soft: #fff6e8;
        --danger-soft: #fff0f0;
      }

      * {
        box-sizing: border-box;
      }

      body {
        margin: 0;
        font-family: "Segoe UI", Tahoma, Arial, sans-serif;
        color: var(--ink);
        background:
          radial-gradient(circle at 86% 7%, #ffd8d4 0%, transparent 30%),
          radial-gradient(circle at 7% 22%, #dff6ff 0%, transparent 24%),
          var(--bg);
      }

      .wrap {
        width: min(1240px, 94vw);
        margin: 22px auto 34px;
        display: grid;
        grid-template-columns: 290px 1fr;
        gap: 16px;
      }

      .panel {
        background: var(--surface);
        border: 1px solid var(--line);
        border-radius: 16px;
        box-shadow: 0 10px 24px rgba(13, 34, 62, 0.06);
      }

      .toc {
        position: sticky;
        top: 16px;
        max-height: calc(100dvh - 32px);
        overflow: auto;
        padding: 14px;
      }

      .toc h2 {
        margin: 0 0 10px;
        color: var(--brand);
        font-size: 1rem;
      }

      .toc a {
        display: block;
        text-decoration: none;
        color: #354a64;
        border-radius: 8px;
        padding: 7px 9px;
        font-size: 13px;
      }

      .toc a:hover {
        background: #fff4f3;
        color: #6b1f1f;
      }

      .content {
        padding: 0 0 18px;
      }

      .hero {
        padding: 20px;
        border-bottom: 1px solid var(--line);
        background: linear-gradient(160deg, #fffdfd 0%, #fff3f1 58%, #eefbf8 100%);
      }

      .eyebrow {
        display: inline-flex;
        align-items: center;
        min-height: 28px;
        padding: 5px 12px;
        border-radius: 999px;
        background: var(--brand-soft);
        color: #7a1f1f;
        font-size: 12px;
        font-weight: 700;
        margin-bottom: 10px;
      }

      h1 {
        margin: 0;
        color: #5f1b1b;
        font-size: clamp(1.45rem, 2.4vw, 2.08rem);
      }

      .subtitle {
        margin: 8px 0 0;
        color: var(--muted);
        line-height: 1.55;
      }

      .hero-layout {
        margin-top: 14px;
        display: grid;
        grid-template-columns: 1.35fr 0.95fr;
        gap: 12px;
      }

      .hero-grid {
        display: grid;
        grid-template-columns: repeat(4, minmax(0, 1fr));
        gap: 10px;
      }

      .metric {
        border: 1px solid #f0cfcc;
        border-radius: 12px;
        background: #fff;
        padding: 10px;
      }

      .metric .k {
        font-size: 11px;
        color: #7c5959;
        margin-bottom: 6px;
        text-transform: uppercase;
        letter-spacing: 0.3px;
      }

      .metric .v {
        font-size: 14px;
        color: #5f1d1d;
        font-weight: 700;
      }

      .hero-visual {
        border: 1px solid #efd0cd;
        border-radius: 14px;
        background: #fff;
        padding: 10px;
        display: grid;
        gap: 8px;
      }

      .hero-visual h3 {
        margin: 0;
        font-size: 0.95rem;
        color: #6f1f1f;
      }

      .hero-visual p {
        margin: 0;
        font-size: 0.84rem;
        color: #5d758c;
      }

      .hero-visual svg {
        width: 100%;
        height: 180px;
        display: block;
      }

      .section {
        padding: 16px 20px;
        border-bottom: 1px solid #edf3fb;
      }

      .section:last-child {
        border-bottom: none;
      }

      .section h2 {
        margin: 0 0 10px;
        color: #6d1f1f;
        font-size: 1.16rem;
      }

      .section p {
        margin: 0;
        color: #314860;
        line-height: 1.56;
      }

      .stack {
        margin-top: 10px;
        display: grid;
        gap: 10px;
      }

      .grid-2 {
        display: grid;
        grid-template-columns: repeat(2, minmax(0, 1fr));
        gap: 10px;
      }

      .grid-3 {
        display: grid;
        grid-template-columns: repeat(3, minmax(0, 1fr));
        gap: 10px;
      }

      .box {
        border: 1px solid var(--line);
        border-radius: 12px;
        padding: 11px 12px;
        background: #fff;
      }

      .box h3 {
        margin: 0 0 7px;
        font-size: 0.97rem;
        color: #1f4061;
      }

      .box p {
        margin: 0;
      }

      .box ul {
        margin: 0 0 0 17px;
        padding: 0;
      }

      .box li {
        margin: 4px 0;
        color: #304860;
      }

      .table {
        margin-top: 8px;
        width: 100%;
        border-collapse: collapse;
        border-radius: 12px;
        border: 1px solid var(--line);
        overflow: hidden;
      }

      .table th,
      .table td {
        padding: 10px;
        text-align: left;
        font-size: 14px;
        border-bottom: 1px solid #e8eff8;
        vertical-align: top;
      }

      .table th {
        background: #fff4f3;
        color: #6f1f1f;
      }

      .table tr:last-child td {
        border-bottom: none;
      }

      .chips {
        margin-top: 8px;
        display: flex;
        gap: 8px;
        flex-wrap: wrap;
      }

      .chip {
        display: inline-flex;
        align-items: center;
        min-height: 30px;
        padding: 4px 10px;
        border-radius: 999px;
        border: 1px solid #d8e4f2;
        background: #f8fbff;
        color: #254764;
        font-size: 13px;
        font-weight: 600;
      }

      .callout {
        margin-top: 10px;
        border-left: 4px solid #0f766e;
        border-radius: 10px;
        background: var(--teal-soft);
        color: #175358;
        padding: 10px 12px;
      }

      .callout.warn {
        border-left-color: #b66a00;
        background: var(--warn-soft);
        color: #7c5b1d;
      }

      .callout.alert {
        border-left-color: #b91c1c;
        background: var(--danger-soft);
        color: #6d2222;
      }

      .flow {
        margin-top: 10px;
        display: grid;
        gap: 9px;
      }

      .step {
        border: 1px solid #d5e3f4;
        border-radius: 12px;
        padding: 10px 11px;
        background: #f9fcff;
      }

      .step strong {
        color: #6d1f1f;
      }

      .arrow {
        width: 30px;
        height: 30px;
        margin: 0 auto;
        border-radius: 999px;
        border: 1px solid #c9d8ec;
        background: #f6fbff;
        color: #456887;
        font-weight: 900;
        display: grid;
        place-items: center;
        line-height: 1;
      }

      .diagram-card {
        margin-top: 10px;
        border: 1px solid #d8e4f2;
        border-radius: 12px;
        background: #fbfdff;
        padding: 11px;
      }

      .diagram-title {
        margin: 0 0 8px;
        font-size: 0.9rem;
        color: #1d3f62;
        font-weight: 700;
      }

      .diagram-card svg {
        width: 100%;
        height: auto;
        display: block;
      }

      .refs a {
        color: #145aa9;
        text-decoration: none;
        word-break: break-word;
      }

      .refs a:hover {
        text-decoration: underline;
      }

      @media (max-width: 1040px) {
        .wrap {
          grid-template-columns: 1fr;
        }

        .toc {
          position: static;
          max-height: none;
        }

        .hero-layout {
          grid-template-columns: 1fr;
        }

        .hero-grid {
          grid-template-columns: repeat(2, minmax(0, 1fr));
        }
      }

      @media (max-width: 760px) {
        .grid-2,
        .grid-3,
        .hero-grid {
          grid-template-columns: 1fr;
        }
      }
    </style>
  </head>
  <body>
    <div class="wrap">
      <aside class="panel toc">
        <h2>On This Page</h2>
        <a href="#what-is-ihd">1. What Is Ischemic Heart Disease?</a>
        <a href="#pathophysiology">2. Pathophysiology</a>
        <a href="#clinical-classification">3. Clinical Classification</a>
        <a href="#stable-angina-management">4. Stable Angina Management</a>
        <a href="#acs-management">5. ACS Management</a>
        <a href="#secondary-prevention">6. Secondary Prevention</a>
        <a href="#recap-drill">Recap Drill</a>
        <a href="#exam-traps">7. Common Exam Traps</a>
        <a href="#quick-revision">8. Quick Revision Summary</a>
      </aside>

      <article class="panel content">
        <header class="hero">
          <span class="eyebrow">Cardiovascular Disorders</span>
          <h1>Ischemic Heart Disease (IHD)</h1>
          <p class="subtitle">
            Clinical Overview and Exam Mastery Guide covering stable angina,
            acute coronary syndromes, core pharmacology, reperfusion strategy,
            and secondary prevention.
          </p>

          <div class="hero-layout">
            <div class="hero-grid">
              <div class="metric">
                <div class="k">Core Disease</div>
                <div class="v">Coronary flow-limiting atherosclerosis</div>
              </div>
              <div class="metric">
                <div class="k">Stable Pattern</div>
                <div class="v">Predictable exertional angina</div>
              </div>
              <div class="metric">
                <div class="k">ACS Driver</div>
                <div class="v">Plaque rupture plus thrombosis</div>
              </div>
              <div class="metric">
                <div class="k">STEMI Priority</div>
                <div class="v">Immediate reperfusion (PCI)</div>
              </div>
            </div>

            <div class="hero-visual">
              <h3>Coronary Occlusion Visual</h3>
              <svg viewBox="0 0 420 190" aria-label="IHD coronary artery visual">
                <rect x="1" y="1" width="418" height="188" rx="14" fill="#fff9f8" stroke="#edd2ce"></rect>
                <rect x="28" y="58" width="360" height="30" rx="15" fill="#fde9e7" stroke="#efc8c3"></rect>
                <rect x="28" y="58" width="360" height="30" rx="15" fill="none" stroke="#cf4b4b" stroke-width="2"></rect>
                <ellipse cx="236" cy="73" rx="62" ry="18" fill="#f9c0b7"></ellipse>
                <ellipse cx="236" cy="73" rx="36" ry="10" fill="#e55d52"></ellipse>
                <text x="198" y="76" fill="#ffffff" font-size="10" font-weight="700">Plaque</text>
                <line x1="236" y1="90" x2="236" y2="136" stroke="#a82d2d" stroke-width="2"></line>
                <polygon points="236,136 230,126 242,126" fill="#a82d2d"></polygon>
                <rect x="164" y="136" width="144" height="34" rx="8" fill="#fff0f0" stroke="#f2c6c6"></rect>
                <text x="178" y="156" fill="#8d1b1b" font-size="11" font-weight="700">Reduced myocardial flow</text>
                <text x="42" y="48" fill="#6b1f1f" font-size="11" font-weight="700">Coronary artery lumen</text>
              </svg>
              <p>Progressive narrowing limits oxygen delivery and triggers ischemic symptoms/events.</p>
            </div>
          </div>
        </header>

        <section class="section" id="what-is-ihd">
          <h2>1. What Is Ischemic Heart Disease?</h2>
          <p>
            Ischemic Heart Disease (IHD), also called Coronary Artery Disease
            (CAD), occurs when coronary arteries are narrowed or blocked by
            atherosclerosis, reducing blood flow to myocardium.
          </p>
          <div class="chips">
            <span class="chip">Angina</span>
            <span class="chip">Myocardial infarction</span>
            <span class="chip">Arrhythmias</span>
            <span class="chip">Sudden cardiac death</span>
          </div>
        </section>

        <section class="section" id="pathophysiology">
          <h2>2. Pathophysiology</h2>
          <div class="flow">
            <div class="step"><strong>Step 1:</strong> Atherosclerotic plaque formation</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Step 2:</strong> Plaque rupture</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Step 3:</strong> Platelet activation</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Step 4:</strong> Thrombus formation and coronary occlusion</div>
          </div>

          <div class="diagram-card">
            <p class="diagram-title">Stable Angina vs ACS Pathway Diagram</p>
            <svg viewBox="0 0 930 250" aria-label="IHD stable vs ACS diagram">
              <rect x="24" y="100" width="240" height="58" rx="11" fill="#ffffff" stroke="#d8e4f2"></rect>
              <text x="45" y="126" fill="#1f3f5f" font-size="14" font-weight="700">Atherosclerotic plaque</text>
              <text x="45" y="144" fill="#5a7690" font-size="12">Coronary narrowing</text>

              <line x1="264" y1="129" x2="360" y2="70" stroke="#2f7d73" stroke-width="2"></line>
              <polygon points="360,70 350,68 355,77" fill="#2f7d73"></polygon>
              <line x1="264" y1="129" x2="360" y2="189" stroke="#b11f1f" stroke-width="2"></line>
              <polygon points="360,189 355,180 350,191" fill="#b11f1f"></polygon>

              <rect x="360" y="38" width="244" height="64" rx="11" fill="#eefaf8" stroke="#caeadf"></rect>
              <text x="380" y="64" fill="#11645a" font-size="14" font-weight="700">Stable plaque</text>
              <text x="380" y="83" fill="#4c746f" font-size="12">Demand ischemia, exertional pain</text>

              <rect x="360" y="157" width="244" height="64" rx="11" fill="#fff1f1" stroke="#f2cbcb"></rect>
              <text x="380" y="183" fill="#8b1a1a" font-size="14" font-weight="700">Plaque rupture + clot</text>
              <text x="380" y="202" fill="#8d5858" font-size="12">Acute coronary syndromes</text>

              <line x1="604" y1="70" x2="700" y2="70" stroke="#2f7d73" stroke-width="2"></line>
              <polygon points="700,70 690,64 690,76" fill="#2f7d73"></polygon>
              <line x1="604" y1="189" x2="700" y2="189" stroke="#b11f1f" stroke-width="2"></line>
              <polygon points="700,189 690,183 690,195" fill="#b11f1f"></polygon>

              <rect x="700" y="38" width="206" height="64" rx="11" fill="#ffffff" stroke="#d8e4f2"></rect>
              <text x="720" y="64" fill="#11645a" font-size="13" font-weight="700">Stable angina</text>
              <text x="720" y="83" fill="#5a7690" font-size="12">Relief with rest or nitro</text>

              <rect x="700" y="157" width="206" height="64" rx="11" fill="#ffffff" stroke="#d8e4f2"></rect>
              <text x="720" y="183" fill="#8b1a1a" font-size="13" font-weight="700">UA / NSTEMI / STEMI</text>
              <text x="720" y="202" fill="#6f4f4f" font-size="12">Urgent ACS pathway</text>
            </svg>
          </div>

          <div class="callout warn">
            Stable plaque leads to stable angina. Plaque rupture with thrombosis
            leads to ACS.
          </div>
        </section>

        <section class="section" id="clinical-classification">
          <h2>3. Clinical Classification</h2>
          <div class="grid-2">
            <div class="box">
              <h3>A. Stable Angina</h3>
              <ul>
                <li>Predictable chest pain</li>
                <li>Triggered by exertion</li>
                <li>Relieved by rest or nitroglycerin</li>
              </ul>
            </div>
            <div class="box">
              <h3>B. Acute Coronary Syndromes (ACS)</h3>
              <ul>
                <li>Unstable angina</li>
                <li>NSTEMI</li>
                <li>STEMI</li>
              </ul>
            </div>
          </div>
          <div class="callout alert">ACS is plaque rupture plus thrombosis until proven otherwise.</div>
        </section>

        <section class="section" id="stable-angina-management">
          <h2>4. Management of Stable Angina</h2>
          <p>Goals: reduce symptoms, prevent progression, reduce mortality.</p>

          <div class="stack">
            <div class="box">
              <h3>A. Nitrates (Nitroglycerin)</h3>
              <div class="grid-2">
                <div>
                  <p><strong>MOA</strong></p>
                  <ul>
                    <li>Converted to nitric oxide</li>
                    <li>Venous vasodilation</li>
                    <li>Reduced preload and myocardial oxygen demand</li>
                  </ul>
                </div>
                <div>
                  <p><strong>Use / Safety</strong></p>
                  <ul>
                    <li>Acute angina relief and prophylaxis before exertion</li>
                    <li>Side effects: headache, hypotension, reflex tachycardia</li>
                    <li>Contra: PDE-5 inhibitors, severe hypotension, RV infarction</li>
                  </ul>
                </div>
              </div>
            </div>

            <div class="box">
              <h3>B. Beta Blockers</h3>
              <ul>
                <li>MOA: beta1 blockade lowers HR, contractility, and oxygen demand</li>
                <li>Benefits: reduced post-MI mortality, fewer angina episodes</li>
                <li>Side effects: bradycardia, hypotension, fatigue</li>
                <li>Contraindications: severe bradycardia, cardiogenic shock</li>
              </ul>
            </div>

            <div class="box">
              <h3>C. Calcium Channel Blockers</h3>
              <ul>
                <li>MOA: block L-type calcium channels causing vasodilation and lower afterload</li>
                <li>Useful when beta blockers are contraindicated or insufficient</li>
                <li>Avoid non-DHP agents in HFrEF</li>
              </ul>
            </div>

            <div class="box">
              <h3>D. Ranolazine</h3>
              <ul>
                <li>MOA: inhibits late sodium current and improves relaxation</li>
                <li>Role: refractory angina add-on therapy</li>
                <li>Side effect: QT prolongation</li>
                <li>Contra: baseline significant QT prolongation, strong CYP3A inhibitors</li>
              </ul>
            </div>
          </div>
        </section>

        <section class="section" id="acs-management">
          <h2>5. Management of Acute Coronary Syndromes (ACS)</h2>
          <p>
            Immediate priorities: restore perfusion, prevent clot propagation,
            and reduce myocardial workload.
          </p>

          <div class="stack">
            <div class="box">
              <h3>A. Antiplatelet Therapy</h3>
              <div class="grid-2">
                <div>
                  <p><strong>Aspirin</strong></p>
                  <ul>
                    <li>MOA: irreversible COX-1 inhibition, lower thromboxane A2</li>
                    <li>Side effects: GI bleeding, dyspepsia</li>
                    <li>Contra: active bleeding</li>
                  </ul>
                </div>
                <div>
                  <p><strong>P2Y12 Inhibitors</strong></p>
                  <ul>
                    <li>Clopidogrel, ticagrelor, prasugrel</li>
                    <li>MOA: ADP receptor blockade, reduced platelet aggregation</li>
                    <li>Side effects: bleeding, dyspnea (ticagrelor)</li>
                    <li>Contra: active bleeding, prior stroke (prasugrel)</li>
                  </ul>
                </div>
              </div>
            </div>

            <div class="box">
              <h3>B. Anticoagulants</h3>
              <ul>
                <li>Heparin, enoxaparin</li>
                <li>MOA: potentiate antithrombin, inhibit thrombin and factor Xa</li>
                <li>Side effects: bleeding, HIT (heparin)</li>
              </ul>
            </div>

            <div class="box">
              <h3>C. High-Intensity Statins</h3>
              <ul>
                <li>Atorvastatin, rosuvastatin</li>
                <li>MOA: HMG-CoA reductase inhibition, lower cholesterol synthesis, stabilize plaque</li>
                <li>Benefits: lower recurrent events and improve survival</li>
                <li>Side effects: myopathy, elevated liver enzymes</li>
                <li>Contraindications: active liver disease, pregnancy</li>
              </ul>
            </div>

            <div class="box">
              <h3>D. Reperfusion</h3>
              <ul>
                <li>STEMI: PCI preferred, fibrinolysis if PCI unavailable</li>
                <li>NSTEMI: risk stratification, early invasive strategy for high-risk patients</li>
              </ul>
            </div>
          </div>

          <div class="diagram-card">
            <p class="diagram-title">ACS Immediate Management Flow Diagram</p>
            <svg viewBox="0 0 940 290" aria-label="ACS algorithm diagram">
              <rect x="20" y="20" width="220" height="56" rx="11" fill="#ffffff" stroke="#d8e4f2"></rect>
              <text x="38" y="46" fill="#1f3f5f" font-size="13" font-weight="700">Suspected ACS</text>
              <text x="38" y="63" fill="#5a7690" font-size="12">ECG + troponin + vitals</text>

              <rect x="278" y="20" width="176" height="56" rx="11" fill="#fff4f3" stroke="#f0d0cd"></rect>
              <text x="294" y="46" fill="#6f1f1f" font-size="13" font-weight="700">Aspirin now</text>
              <text x="294" y="63" fill="#7c5d5d" font-size="12">Start antiplatelet base</text>

              <rect x="492" y="20" width="188" height="56" rx="11" fill="#fff4f3" stroke="#f0d0cd"></rect>
              <text x="508" y="46" fill="#6f1f1f" font-size="13" font-weight="700">Add P2Y12 inhibitor</text>
              <text x="508" y="63" fill="#7c5d5d" font-size="12">DAPT strategy</text>

              <rect x="718" y="20" width="202" height="56" rx="11" fill="#eefbf8" stroke="#caeadf"></rect>
              <text x="734" y="46" fill="#126458" font-size="13" font-weight="700">Anticoagulation + statin</text>
              <text x="734" y="63" fill="#4b746f" font-size="12">Heparin/LMWH + high-intensity statin</text>

              <line x1="240" y1="48" x2="278" y2="48" stroke="#5f7da1" stroke-width="2"></line>
              <polygon points="278,48 268,42 268,54" fill="#5f7da1"></polygon>
              <line x1="454" y1="48" x2="492" y2="48" stroke="#5f7da1" stroke-width="2"></line>
              <polygon points="492,48 482,42 482,54" fill="#5f7da1"></polygon>
              <line x1="680" y1="48" x2="718" y2="48" stroke="#5f7da1" stroke-width="2"></line>
              <polygon points="718,48 708,42 708,54" fill="#5f7da1"></polygon>

              <line x1="819" y1="76" x2="819" y2="122" stroke="#b56a10" stroke-width="2"></line>
              <polygon points="819,122 813,112 825,112" fill="#b56a10"></polygon>

              <rect x="698" y="122" width="222" height="56" rx="11" fill="#fff7ea" stroke="#f2debf"></rect>
              <text x="714" y="148" fill="#9a5b06" font-size="13" font-weight="700">STEMI?</text>
              <text x="714" y="165" fill="#80693f" font-size="12">Immediate reperfusion decision</text>

              <line x1="698" y1="150" x2="560" y2="214" stroke="#b11f1f" stroke-width="2"></line>
              <polygon points="560,214 567,205 571,216" fill="#b11f1f"></polygon>
              <line x1="920" y1="150" x2="920" y2="214" stroke="#2f7d73" stroke-width="2"></line>
              <polygon points="920,214 914,204 926,204" fill="#2f7d73"></polygon>

              <rect x="392" y="214" width="312" height="60" rx="11" fill="#fff1f1" stroke="#f2cbcb"></rect>
              <text x="410" y="240" fill="#8b1a1a" font-size="13" font-weight="700">STEMI: PCI preferred</text>
              <text x="410" y="258" fill="#8d5959" font-size="12">Fibrinolysis if PCI cannot be delivered in time</text>

              <rect x="726" y="214" width="194" height="60" rx="11" fill="#eefaf8" stroke="#caeadf"></rect>
              <text x="742" y="240" fill="#126458" font-size="13" font-weight="700">NSTEMI/UA</text>
              <text x="742" y="258" fill="#4b746f" font-size="12">Risk stratify and consider early invasive strategy</text>
            </svg>
          </div>
        </section>

        <section class="section" id="secondary-prevention">
          <h2>6. Secondary Prevention</h2>
          <p>All post-MI patients should receive:</p>
          <div class="chips">
            <span class="chip">DAPT</span>
            <span class="chip">Beta blocker</span>
            <span class="chip">ACE inhibitor</span>
            <span class="chip">High-intensity statin</span>
          </div>
          <div class="callout">Lifestyle modification remains mandatory.</div>
        </section>

        <section class="section" id="recap-drill">
          <h2>Management Recap Drill</h2>
          <div class="flow">
            <div class="step"><strong>Stable angina:</strong> Nitroglycerin for acute relief</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Chronic control:</strong> Beta blocker first-line</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Escalate if needed:</strong> Add CCB or ranolazine</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>ACS sequence:</strong> Aspirin -> P2Y12 -> anticoagulation -> statin -> reperfusion</div>
          </div>
        </section>

        <section class="section refs">
          <h2>Guideline References</h2>
          <div class="grid-2">
            <div class="box">
              <h3>ACC/AHA Guideline for Chronic Coronary Disease</h3>
              <a
                href="https://www.acc.org/guidelines"
                target="_blank"
                rel="noopener"
              >
                https://www.acc.org/guidelines
              </a>
            </div>
            <div class="box">
              <h3>ACC/AHA Guideline for Acute Coronary Syndromes</h3>
              <a
                href="https://www.acc.org/guidelines"
                target="_blank"
                rel="noopener"
              >
                https://www.acc.org/guidelines
              </a>
            </div>
          </div>
        </section>

        <section class="section" id="exam-traps">
          <h2>7. Common Exam Traps</h2>
          <div class="stack">
            <div class="callout alert">Do not combine nitrates with PDE-5 inhibitors.</div>
            <div class="callout alert">Prasugrel is contraindicated with prior stroke history.</div>
            <div class="callout alert">Beta blockers reduce mortality after myocardial infarction.</div>
            <div class="callout alert">Post-ACS statin therapy is required even with normal LDL.</div>
            <div class="callout alert">STEMI requires urgent reperfusion strategy.</div>
          </div>
        </section>

        <section class="section" id="quick-revision">
          <h2>8. Quick Revision Summary</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Must Remember</h3>
              <ul>
                <li>Stable angina is demand ischemia</li>
                <li>ACS is plaque rupture until proven otherwise</li>
                <li>MONA is outdated; prioritize DAPT plus anticoagulation</li>
                <li>STEMI points to urgent PCI pathway</li>
              </ul>
            </div>
            <div class="box">
              <h3>Post-MI Core Bundle</h3>
              <ul>
                <li>High-intensity statin</li>
                <li>Beta blocker</li>
                <li>ACE inhibitor</li>
                <li>DAPT and risk-factor control</li>
              </ul>
            </div>
          </div>

          <div class="stack">
            <div class="box">
              <h3>Practice Questions Placeholder</h3>
              <ul>
                <li>Topic: Ischemic Heart Disease</li>
                <li>Subtopics: stable angina, NSTEMI, STEMI, DAPT, secondary prevention</li>
              </ul>
            </div>
          </div>
        </section>
      </article>
    </div>
  </body>
</html>
